The Role of Arginine Metabolism in Oral Tongue Squamous Cell Carcinoma
Authors:
- Leanne Lee LeungLLLeanne Lee Leung
- Nicolas Cheuk Hang LauNLNicolas Cheuk Hang Lau
- Jiaxun LiuJLJiaxun Liu
- Xinyu QuXQXinyu Qu
- Stephen Kwok-Wing TsuiStephen Kwok-Wing Tsui
- Jinpao HouJHJinpao Hou
- Cherie Tsz-Yiu LawCLCherie Tsz-Yiu Law
- Tung Him NgTNTung Him Ng
- Judy Wai Ping YamJYJudy Wai Ping Yam
- Chit ChowCCChit Chow
- Amy B. W. ChanACAmy B. W. Chan
- Jason Y. K. ChanJason Y. K. Chan
Open Access
Abstract
Early diagnosis and treatment do not prevent the high morbidity and poor prognosis of oral tongue squamous cell carcinoma (TSCC). Earlier studies have shown that ARG1 signaling is deregulated in TSCC. Here, we investigated the complexity of ARG1 metabolism in this cancer subsite to appreciate the therapeutic potential of this potential biological vulnerability. Various functional studies show that ARG1 overexpression in oral cancer cells inhibits cell proliferation and invasion compared with controls. Further, RNA-sequencing revealed numerous differentially expressed genes (DEGs) and associated networks were dysregulated by ARG1 overexpression, including hypoxia-inducible factor (HIFα) signaling, the natural killer cell signaling pathway and interferon signaling. Our work provides a foundation for understanding the mechanism of action of disrupted arginine metabolism in oral tongue squamous cell carcinoma. This may impact the community for developing further therapeutic approaches.Keywords
Funding Information
- United College Endowment Fund (CUHK2020)
This publication has 29 references indexed in Scilit:
- Oral Cavity Carcinoma: Current Management, Controversies, and Future DirectionsJournal of Clinical Oncology, 2015
- HIF-1α pathway: role, regulation and intervention for cancer therapyActa Pharmaceutica Sinica B, 2015
- Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid TumorsClinical Cancer Research, 2015
- Tissue-based map of the human proteomeScience, 2015
- Arginine deprivation as a new treatment strategy for head and neck cancerOral Oncology, 2012
- Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survivalThe American Journal of Clinical Nutrition, 2010
- Pegylated arginase I: a potential therapeutic approach in T-ALLBlood, 2010
- Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationBlood, 2007
- Clinical and biochemical outcomes after a randomized trial with a high dose of enteral arginine formula in postsurgical head and neck cancer patientsEuropean Journal of Clinical Nutrition, 2006
- Effects of iron-chelators on ion-channels and HIF-1α in the carotid bodyRespiratory Physiology & Neurobiology, 2004